| Literature DB >> 27742108 |
Jerrold L Boxerman1, Mark S Shiroishi2, Benjamin M Ellingson3, Whitney B Pope4.
Abstract
Dynamic susceptibility contrast (DSC) MR imaging, a perfusion-weighted MR imaging technique typically used in neuro-oncologic applications for estimating the relative cerebral blood volume within brain tumors, has demonstrated much potential for determining prognosis, predicting therapeutic response, and assessing early treatment response of gliomas. This review highlights recent developments using DSC-MR imaging and emphasizes the need for technical standardization and validation in prospective studies in order for this technique to become incorporated into standard-of-care imaging for patients with brain tumors.Entities:
Keywords: Cerebral blood volume (CBV); Dynamic susceptibility contrast MR imaging (DSC-MR imaging); Glioblastoma; High-grade glioma; Prognosis; Pseudoprogression; Pseudoresponse; Response assessment
Mesh：
Substances：
Year: 2016 PMID： 27742108 DOI： 10.1016/j.mric.2016.06.005
Source DB: PubMed Journal: Magn Reson Imaging Clin N Am ISSN： 1064-9689 Impact factor: 2.266